| Literature DB >> 33061261 |
Jonathan W Young1, Nathan W Law2, Daniel C Tu2,3.
Abstract
PURPOSE: Patients and physicians are often pleased when uncorrected visual acuity (UCVA) on post-operative day 1 (POD1) after cataract surgery is 20/20. Unfortunately, this UCVA does not always last. This article aims to investigate the relationship between excellent uncorrected visual acuity on post-operative day 1 and final post-operative UCVA after uncomplicated cataract surgery. PATIENTS AND METHODS: The medical records of patients who had undergone uncomplicated cataract surgery between 2012 and 2017 were assessed. UCVA on POD1 and final UCVA were obtained for patients who had a final best-corrected visual acuity of 20/20 or better.Entities:
Keywords: cataract; phacoemulsification; pseudophakia; treatment outcome; visual acuity
Year: 2020 PMID: 33061261 PMCID: PMC7520138 DOI: 10.2147/OPTH.S267081
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Figure 1Distribution of final post-operative UCVA for all patients who achieved 20/20 on POD1 (n = 309).
Figure 2Distribution of final post-operative UCVA for all patients who achieved 20/25 on POD1 (n = 204).
Figure 3Distribution of final post-operative UCVA for patients who achieved 20/20 on POD1 after excluding patients who were seen in sub-specialty clinics (n = 216).
Figure 4Distribution of final post-operative UCVA for patients who achieved 20/25 on POD1 after excluding patients who were seen in sub-specialty clinics (n = 143).
Figure 5Cumulative distribution plots showing final post-operative UCVA among different surgeon groups. These distributions were not statistically different.
Characteristics Comparing Outliers Who Lost >2 Lines of UCVA from POD1 (and Did Not Receive Intracameral Carbachol) with Those Who Were Able to Maintain Excellent UCVA. Mean and (Std. Dev) Shown. No Significant Differences Between Characteristics Were Found
| IOP on POD1 | Age | Preoperative Spherical Equivalent | % Female | |
|---|---|---|---|---|
| Outliers who lost >2 lines (n=21) | 15.8 (5.7) | 66.6 (11.2) | −0.85 (1.34) | 52 |
| All patients with 20/25 UCVA on POD1 who maintained VA (n=482) | 17.4 (4.8) | 65.6 (10.4) | −1.81 (3.87) | 49.9 |
| P value for difference | 0.13 | 0.66 | 0.25 | 0.85 |